Cramer Recommends J&J For Best Big Pharma Pipeline Play

Coming out of the Twittersphere Wednesday afternoon: a trader asks Jim Cramer about a potential big pharma play which could fit into his or her portfolio. The trader specified the play would need to be for over the next five years. Cramer responded:

$JNJ RT @MrFlyTrap: @jimcramer Jim, want to add big Pharma to my port. who has best pipeline & who will be best in breed 5 years

— Jim Cramer (@jimcramer) March 5, 2014

J&J JNJ shares do not seem to be responding to the recommendation by Cramer, but are trading at afternoon highs. The stock is down 0.6 percent to $92.74 at last check.